首页> 外文期刊>Arthritis research & therapy. >Efficacy of an immunotoxin to folate receptor beta in the intra-articular treatment of antigen-induced arthritis
【24h】

Efficacy of an immunotoxin to folate receptor beta in the intra-articular treatment of antigen-induced arthritis

机译:免疫毒素对叶酸受体β的关节内治疗抗原诱导的关节炎的功效

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: We previously demonstrated that synovial sublining macrophages express folate receptor beta (FRβ). The aim of this study was to evaluate the efficacy of intra-articular administration of a recombinant immunotoxin to FRβ for treating rat antigen-induced arthritis.Methods: A monoclonal antibody (mAb) to rat FRβ was produced by immunizing mice with B300-19 cells (murine pre-B cells) transfected with the rat FRβ gene. Recombinant immunotoxin was prepared by conjugating the Fv portion of the anti-rat FRβ mAb heavy chain with a truncated Pseudomonas exotoxin A and the Fv portion of the anti-rat FRβ mAb light chain. Antigen-induced arthritis was induced through intra-articular injection of methylated bovine serum albumin (mBSA) after two subcutaneous injections of mBSA and complete Freund's adjuvant. Immunotoxin was intra-articularly injected into the arthritis joint every other day for seven days after arthritis onset. Joint swelling was measured and histological scores of inflammation, synovial thickness, cartilage, and bone destruction were determined. Immunohistochemistry was performed to detect osteoclast and osteoclast precursor FRβ-expressing macrophages and cathepsin K-positive cells on day 21.Results: Intra-articular administration of the immunotoxin attenuated joint swelling (61% suppression; P < 0.01 compared to the control on day 21) and improved histological findings, particularly cartilage and bone destruction (scores of rats treated with control versus the immunotoxin: 2.2 versus 0.5; P < 0.01), by reducing the number of FRβ-expressing macrophages and cathepsin K-positive cells.Conclusions: Intra-articular administration of an immunotoxin to FRβ is effective for improving rat antigen-induced arthritis.
机译:简介:我们先前证明滑膜下巨噬细胞表达叶酸受体β(FRβ)。这项研究的目的是评估关节内给予FRβ的重组免疫毒素治疗大鼠抗原诱导的关节炎的有效性。方法:通过用B300-19细胞免疫小鼠,产生针对大鼠FRβ的单克隆抗体(mAb)大鼠FRβ基因转染的(鼠B前体细胞)。通过将抗大鼠FRβmAb重链的Fv部分与截短的假单胞菌外毒素A和抗大鼠FRβmAb轻链的Fv部分缀合来制备重组免疫毒素。两次皮下注射mBSA和完全弗氏佐剂后,通过关节内注射甲基化牛血清白蛋白(mBSA)诱导抗原诱导的关节炎。在关节炎发作后的七天中,每隔一天将免疫毒素关节内注射到关节炎关节中。测量关节肿胀并确定炎症,滑膜厚度,软骨和骨破坏的组织学评分。在第21天进行免疫组织化学检测破骨细胞和破骨细胞前体表达FRβ的巨噬细胞和组织蛋白酶K阳性细胞。结果:关节内给予免疫毒素可减轻关节肿胀(抑制61%;与第21天的对照组相比,P <0.01 ),并通过减少表达FRβ的巨噬细胞和组织蛋白酶K阳性细胞的数量,改善了组织学发现,尤其是软骨和骨破坏(对照组与免疫毒素治疗的大鼠的分数:2.2与0.5; P <0.01)。对FRβ的免疫毒素的关节给药对于改善大鼠抗原诱导的关节炎是有效的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号